# Humacyte, Inc.: Form 8-K, filed Sep 2, 2021

- Company: [Humacyte, Inc.](/companies/huma.md) (CIK 1818382)
- Form: 8-K
- Filed: 2021-09-02
- Accepted by EDGAR: Sep 2, 2021, 12:20 ET
- Period: 2021-08-27
- Accession: 0001104659-21-112356
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818382/000110465921112356/tm2126886d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818382/000110465921112356/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818382/000110465921112356/tm2126886d1_8k.htm

Filed Sep 2, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-112356. Last ingested by Listed: Nov 11, 2026, 01:52 ET. No prices; not investment advice.
